TRIL
Geode Capital Management’s Trillium Therapeutics Inc. TRIL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-850,207
| Closed | -$14.9M | – | 5036 |
|
|
2021
Q3 | $14.9M | Buy |
850,207
+10,318
| +1% | +$181K | ﹤0.01% | 2167 |
|
|
2021
Q2 | $8.15M | Buy |
839,889
+766,327
| +1,042% | +$7.43M | ﹤0.01% | 2604 |
|
|
2021
Q1 | $810K | Buy |
73,562
+2,105
| +3% | +$23.2K | ﹤0.01% | 3646 |
|
|
2020
Q4 | $1.07M | Buy |
71,457
+55,795
| +356% | +$838K | ﹤0.01% | 3351 |
|
|
2020
Q3 | $222K | Sell |
15,662
-1,586
| -9% | -$22.5K | ﹤0.01% | 3684 |
|
|
2020
Q2 | $139K | Hold |
17,248
| – | – | ﹤0.01% | 3771 |
|
|
2020
Q1 | $69K | Sell |
17,248
-85,477
| -83% | -$342K | ﹤0.01% | 3860 |
|
|
2019
Q4 | $105K | Hold |
102,725
| – | – | ﹤0.01% | 3972 |
|
|
2019
Q3 | $31K | Hold |
102,725
| – | – | ﹤0.01% | 4110 |
|
|
2019
Q2 | $33K | Buy |
102,725
+76,098
| +286% | +$24.4K | ﹤0.01% | 4122 |
|
|
2019
Q1 | $17K | Hold |
26,627
| – | – | ﹤0.01% | 4104 |
|
|
2018
Q4 | $45K | Buy |
26,627
+16,541
| +164% | +$28K | ﹤0.01% | 4012 |
|
|
2018
Q3 | $58K | Hold |
10,086
| – | – | ﹤0.01% | 4015 |
|
|
2018
Q2 | $60K | Buy |
+10,086
| New | +$60K | ﹤0.01% | 3960 |
|